Impella heart pump study in ICU
Part of Heart & circulation clinical trials.
This study is for people in the intensive care unit who are using a heart pump called Impella. It will collect information about how well the heart pumps blood during treatment to help doctors learn more.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently hospitalized in an intensive care unit (ICU) or will be admitted to one.
- You are receiving or will receive a heart pump called Impella to help your heart.
- You have a way to measure your heart's pumping ability (cardiac output), such as a pulmonary artery catheter or echocardiogram.
- You are 18 years old or older.
- You are not pregnant.
- Your Impella support is expected to last at least 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether a temporary heart pump (Impella) can help people with severe heart failure and cardiogenic shock (when the heart can't pump enough blood). The goal is to see if this device can reduce fluid buildup and improve blood flow, but it's for people who are very ill and need extra support.
This study reviews how well people tolerated the Impella heart pump during cardiogenic shock and what complications occurred. It looks at past cases from 2010 to 2022 to help doctors understand the safety of this device.
This study examines detailed data from patients who received an Impella 5.5 heart pump to treat cardiogenic shock—a life-threatening condition where the heart cannot pump enough blood. Researchers use advanced computer analysis to understand what helps patients recover best.
This study compares two support devices (Impella vs. IABP) for people with cardiogenic shock who are already on ECMO. It looks at how well the left side of the heart recovers when one of these devices is added.
This study tests whether a special heart pump (Impella 5.5) can help patients with severe heart failure (cardiogenic shock) safely start and increase their heart failure medications. The goal is to see if this approach can help the heart recover and improve outcomes.
This study looks at when to insert a small heart pump (Impella CP) in people who have had a heart attack and are in cardiogenic shock, a condition where the heart can't pump enough blood. The goal is to find out if placing the pump before or after the artery-opening procedure improves outcomes.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.